The brain plays a central role in the pathophysiology of obesity. Predictive Modeling (CPM) is a newly developed, data-driven approach that exploits whole-48 brain functional connectivity to predict a behavior or trait that varies across individuals. We used 49 CPM to determine whether brain "fingerprints" evoked during milkshake consumption could be 50 isolated for common measures of adiposity in 67 overweight and obese adults. We found that a 51 CPM could be identified for waist circumference, but not percent body fat or BMI, the most 52 frequently used measures to assess brain correlates of obesity. In an exploratory analysis, we 53 were also able to derive a largely distinct CPM predicting fasting blood insulin. These findings 54 demonstrate that brain network patterns are more tightly coupled to waist circumference than 55 BMI or percent body fat and that adiposity and glucose tolerance are associated with distinct 56 maps, pointing to dissociable central pathophysiological phenotypes for obesity and diabetes. 57
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Introduction 61
Obesity is a neurobehavioral disorder resulting from a biologically vulnerable brain that is highly 62 sensitive to its environment (1) . Evidence for this derives from genome-wide association studies 63 (GWAS), demonstrating that genetic variants associated with obesity tend to affect brain 64 function. For example, high-risk variants in the FTO (fat mass and obesity associated) gene 65 predispose individuals to weighing on average 3kg more and increasing their obesity risk 1.67x 66 over those with low-risk variants (2, 3). The FTO gene encodes the alpha-ketoglutarate-67 dependent dioxygenase enzyme, a protein that is highly expressed in the human brain, 68 particularly in the hypothalamus and cerebellum as well as on dopamine receptors where it 69 influences reward learning (4 -6). Hypotheses of FTO's action in the human brain suggest that it 70 may act to increase consumption of food and alter sensing of dietary macronutrient composition 71 (7) . Since the discovery of FTO, additional GWAS have found another 97 BMI-associated SNPs 72 which encode for proteins that are significantly enriched in the human brain (8). 73
While the vast majority of evidence continues to point to the brain as integral in the 74 pathophysiology of obesity, none of the adiposity measures we have to quantify it or characterize 75 its extent are brain measures. Body mass index, or BMI, is the anthropometric measurement 76 commonly used to classify obesity, with individuals having a BMI ≥ 30 characterized as obese 77 (9). However, BMI as a measure of adiposity is often criticized for being an inaccurate reflection 78 of fat mass, in particular in Asians and in athletes (10, 11) . Body fat percentage alone has also 79 been criticized as an inaccurate predictor of negative health outcomes, as regional distribution of 80 fat in the body influences risk for negative health consequences. For example, women with 81 predominantly upper body adipose tissue are more likely to have diabetic glucose tolerance 82 results and higher fasting plasma triglycerides than those with predominantly lower body adipose 83 tissue (12). More recent studies have found that distribution of adipose tissue, particularly in the 84 thighs, is inversely correlated with metabolic syndrome in obesity (13) . 85
Ultimately, if obesity is a neurobehavioral disorder resulting from a vulnerable brain interacting 86 with an obesogenic environment, the most informative adiposity measures should be predicted 87 by brain function to some extent. Further, if an adiposity measure can be reliably predicted using 88 features of brain function in a cross-validated framework, it follows that these features may 89 represent a generalizable index of adiposity. Thus, not only is it important that we are able to 90 determine which adiposity measure is best predicted by whole-brain functional connectivity, but 91 it also imperative to determine which anatomical regions (i.e. nodes) and which connections 92 among them (i.e. edges) are influencing our predictive power. 93
With this in mind, we set out to determine which commonly-used adiposity measures, including 94 BMI, body fat %, waist size, body weight, and waist/hip ratio, could be predicted by whole-brain 95 function connectivity. To accomplish this, we use connectome-based predictive modeling 96 (CPM), a data-driven approach that builds predictive models of brain-behavior relationships 97 using connectivity data in a cross-validated framework (14, 15). More specifically, CPM exploits 98 individual variation in whole-brain functional connectivity to predict a behavior or trait that 99 varies across individuals in a leave-one-out procedure. CPM has been used to identify brain 100 "fingerprints" (14) as well as to predict personality traits (16), creative ability (17), and sustained 101 attention (18). Here we used this technique to ask whether a predictive CPM could be identified 102 for our different adiposity measures. As an exploratory aim, we also tested whether a CPM could 103 be found for measures of glucose tolerance. 104
Results 106 respectively ( Table 1) . 126
Canonical networks emphasize different functional properties of the human brain and consist of 127 medial frontal (MF), frontoparietal (FP), default mode (DM), motor (MO), visual 1 (V1), visual 128 2 (V2), visual association (VA), cingulo-opercular (CO), subcortical (SC), and cerebellum (CE) 129 networks (19, 20) . The highest proportion of edges, that is, the edges used most in prediction for 130 the positive network exist between DM-V2, MO-CE, V2-VA, and CO-SC. In the negative 131 network, these are between DM-SC, MO-V2, MO-V1, V1-SC, VA-VA, and CE-CE ( Fig. 2B) . 132
Exploratory analysis: CPM predicts individual differences in fasting insulin 133
Due to the large scope of the dataset, we were able to conduct a post-hoc exploratory analysis of 134 metabolic markers to examine convergence or divergence of predictive networks as they relate to 135 the waist circumference CPM. For this analysis, we analyzed additional bloods data until we had 136 a complete metabolic panel from all 59 of 67 subjects. Fasting glucose, fasting insulin, and 137 HOMA-IR were input into CPM as our measures of interest. CPM was able to predict fasting 138 insulin (p < 0.05, uncorrected; Fig. 3A ) but not fasting glucose or HOMA-IR, accounting for 139 approximately 7% of the variance in a novel individual's fasting insulin levels. Positive and 140 negative predictive networks for fasting insulin are notably sparser than those for waist 141 circumference ( Fig. 3B ). High degree nodes (degree ³ 6) for these networks were found in 142 cerebellar (left crus and right lobule VIIB), temporal (left superior temporal pole and right 143 fusiform), and limbic (right posterior cingulate gyrus) regions ( Fig. 3B , see also 5B, Table 2 ). In 144 the positive network, a high density of edges exists between MF-CE, DM-V2, MO-CE, V2-CE, 145 and V2-SC ( Fig. 3C ). In the negative network, these exist between MF-MF, FP-VA, FP-V1, 146 DM-CE, DM-SC, V1-SC, V1-V2, VA-CO, CO-CE, and SC-SC ( Fig. 3C ). 147
Waist circumference and fasting insulin CPMs are separable 148
To examine convergence and divergence of predictive networks, we subtracted the number of 149 negative edges from the number of positive edges between each canonical network and plotted 150 the resultant degree of polarity ( Fig. 4A-B ). For example, networks can have mostly positive or 151 negative edges connecting them (i.e. polarity), or an even distribution of positive and negative 152 edges (i.e. apolarity). Indeed, this technique demonstrates the degree to which positive or 153 negative edges are used in prediction and can help ascertain common or uncommon 154 neurobiological correlates between fasting insulin and waist circumference. The predictive 155 network for waist size shows a large degree of polarity ( Fig. 4A ), while the relative sparsity of 156 the predictive network for insulin is visible and there is notable apolarity particularly among 157 visual networks ( Fig. 4B ). Predictive networks for insulin and waist size are on average 158 dissimilar. Of the 55 network pairs, 26 network pairs (47%) exhibited similar degrees of polarity 159 between the waist circumference and insulin predictive networks. Most notably, patterns of 160 connectivity within cerebellar and subcortical networks showed the most similar patterns of 161 polarity between waist circumference and fasting insulin predictive networks ( Fig. 4) . In contrast 162 their polarity differs most in medial-frontal, frontoparietal, default mode, motor, visual, and 163 cingulo-opercular networks. To aid in comparison, we plotted the spatial extent of the top 10% 164 highest-degree predictive nodes for each network ( The role of subject motion 171
We used frame-to-frame displacement (FTF) as a gross measure of head motion (21). FTF was 172 calculated for each run in each subject and averaged across runs. FTF significantly correlated 173 with waist size (R 2 = 0.199, p < 0.001), BMI (R 2 = 0.115, p < 0.01), body weight (R 2 = 0.132, p 174 < 0.01), waist/hip ratio (R 2 = 0.103, p < 0.01), and BF% (R 2 = 0.107, p < 0.01). FTF was notably 175 not correlated with fasting glucose (r = 0.05, p = 0.68), fasting insulin (r = 0.15, p = 0.25), or 176 HOMA-IR (r = 0.15, p = 0.27). While a correlation between any of our adiposity measures and 177 FTF suggests that motion should be accounted for using partial Pearson correlation, recent 178 evidence suggests that in-scanner head motion is heritable and phenotypically correlated with 179 BMI (22). Indeed, if head motion and adiposity contain shared genetic influences, then 180 controlling for motion in CPM would unnecessarily reduce its predictive power in this instance. 181
Instead we corrected for motion during preprocessing (see Methods) and report results following 182 partial Pearson correlation for mean FTF subject (see Supplementary Table 2 ). Of note, CPMs 183 for both waist circumference and insulin were both significant, but did not survive FDR 184 correction when motion is included as a covariate. 185 186 Discussion 187
Our experiment produced several novel findings. First, we determined, using a data-driven 188 approach, that waist circumference could be predicted by whole-brain functional connectivity. In 189 particular, with CPM we can account for approximately 12.5% of the variance in this measure in 190 a novel individual. Notably, we could not predict BMI, the most commonly used measure to 191 define obesity, or other adiposity measures, such as body fat %, body weight, and waist/hip ratio. 192
Second, we found that a metabolic marker, fasting insulin, could be predicted from whole-brain 193 functional connectivity and that this predictive network was distinct from that of waist 194
circumference. 195
There is long-standing controversy regarding the optimal method to quantify adiposity. We 196 assert that, not only is it important to use a measure that captures an individual's risk for 197 morbidity and mortality, but it is equally important to capture obesity's underpinnings as a 198 neurobehavioral disorder. Waist circumference does both. 199
This proposal is consistent with a number of recent findings. Waist circumference has better 200 discriminatory capability for type 2 diabetes than either BMI or body adiposity index [BAI, 201 calculated as (hip circumference)/((height) 1.5 )-18] in a northern Iranian population (23, 24). A 202 systematic review found that waist circumference performed 3% better than BMI in 203 discriminating adults with hypertension, T2D, metabolic syndrome, dyslipidaemia, and general 204 cardiovascular outcomes (25). A meta-analysis of some 259,200 individuals found that high 205 waist circumference is a better predictor than high BMI for the development of diabetes across 206 all ethnicities tested and for the development of hypertension among Hispanics/Latinos in 207 particular (26). Additional evidence suggests that individuals who are classified as obese by 208 waist circumference have a greater risk for all-cause and cardiovascular disease-related death 209 than individuals who are classified as obese by BMI (27). In a separate cohort of 2266 210 hypertensive patients, waist circumference was able to predict the development of coronary 211 artery disease, while other measures of adiposity such as BMI and waist/hip ratio had no 212 independent prognostic value (28). 213
Although most neuroimaging studies use BMI to assess neural correlates of obesity, when waist 214 circumference is pitted against BMI, stronger and more extensive correlations are often found. 215
For example, waist circumference, is a better predictor of local gray matter volume 216 (29, 30) and brain response to food cues (31 -33). The current study confirms and extends these 217 findings by using functional connectivity and a whole-brain data-driven approach to show that 218 brain measures not only correlate most strongly with waist circumference, but also are able to 219 predict waist circumference. This indicates that this neural measure may act as a biomarker for 220 the measure of adiposity that best predicts obesity-related health outcomes (34). 221
More specifically, high-degree nodes for the waist circumference CPM were located in left 222 inferior frontal gyrus, left postcentral gyrus, left amygdala, the left culmen of the cerebellum, 223 right putamen, and right fusiform gyrus ( Fig. 5A ). Enhanced responses to food-related stimuli 224 can be found in many of these regions and responses in some regions have been associated with 225 weight gain (35, 36). However, in these instances the relationship is correlative. For example, 226 amygdala response to food related stimuli when sated, but not hungry, correlates with 12-month 227 weight gain (37). This suggests that amygdala responsivity to food cues in the absence of hunger 228 is predictive of overeating and weight gain, but it is not a direct test of the hypothesis because the 229 amygdala response could be epiphenomenal. Likewise, response in the right putamen, during 230 milkshake consumption is predictive of weight change with direction depending upon genotype 231 (38). The current results go beyond these findings. CPM presents as a strength its cross-validated 232 framework based on data-driven model optimization. Here we were able to identify brain 233 features that predict and therefore may constitute a neural index of waist circumference. 234
This result raises the question as to how the CPM we have identified contributes to the 235 development of increased waist circumference and conversely, how and why waist 236 circumference specifically influences the identified brain "fingerprint". Notably, although waist 237 circumference is the best adiposity predictor of glucose control, inspection of the anatomy of the 238 CPMs identified for waist circumference and fasting insulin, a marker of insulin resistance, 239 reveals that they are largely distinct (Fig. 5, 6 ) (39 -41). In particular, the CPMs for waist 240 circumference and fasting insulin showed minimal overlap in the highest degree nodes. This 241 suggests there are distinct neuropathophysiological features. The distinction between the CPMs 242 is best captured by their relative polarity, or the number of positive versus negative edges 243 between networks. The cerebellar and subcortical networks show similar patterns of connectivity 244 while patterns in medial-frontal, frontoparietal, default mode, motor, visual, and cingulo-245 opercular networks largely differ. Overlap between cerebellar and subcortical networks for 246 adiposity and metabolic dysfunction suggests that these regions may play an integral role in the 247 pathophysiology of obesity. These observations support future efforts to uncover the link 248 between the distinct networks and their contributions to the causes and consequences of obesity. 249
Our findings also have clinical implications. One important application of neuroimaging in 250 clinical practice, is to enable the prediction of clinical outcomes using brain structure, activity, or 251 connectivity (42). Previous methods in predicting brain-behavior relationships tended to be 252 correlational, and thus would overfit to data and fail to generalize to novel individuals (15). As 253 indicated above, CPM presents as a strength its cross-validated framework, which suggests that 254 the predictive features for waist circumference and fasting insulin are generalizable within novel 255 subjects in this dataset. In other words, it is a window into the brain features that contribute to 256 predicting adiposity and metabolic outcomes and as such may constitute biomarkers to index risk 257 or the efficacy of therapeutic interventions. 258
Further, to apply such a finding to clinical practice, network-based prediction models of obesity 259 must be shown to generalize across samples, populations, and experimental settings (42). A 260 promising avenue to then implement CPM as a tool for clinical use is to use real-time fMRI 261 biofeedback to change connectivity patterns or activation profiles within predictive networks 262 across subjects. Similar approaches have been successfully used in previous studies, namely 263 those attempting to alleviate contamination anxiety, enhance emotion regulation capabilities, and 264 mitigate auditory verbal hallucinations in schizophrenia, among others (43 -45). Another 265 approach, similar to that of Rosenberg et al., 2016 (46), is to treat overweight and obesity using a 266 particular intervention and observe how the predictive networks change. We predict that more 267 efficacious treatments will reduce network strength within networks that predict high waist 268 circumference and fasting insulin, and increase the strength of antithetical networks. Recent 269 work suggests that networks obtained using CPM can predict abstinence during treatment for 270 cocaine dependence (47). If the obtained CPMs are relevant to the pathophysiology of obesity, it 271 is thus possible that they may predict weight loss during an intervention, which would be useful 272 for obese individuals seeking treatment. Finally, not only is waist circumference better than BMI 273 and other adiposity measures at predicting a variety of adverse health-related outcomes, but it is 274 also better predicted from whole-brain functional connectivity using CPM. This suggests that 275 including waist circumference as a measure of interest in a clinical setting is imperative to 276 accurately quantify the extent and progression of obesity. 277
Limitations and future directions 278
This study has a number of limitations to address. First, the sample size was relatively limited for 279 a study implementing CPM. It is quite possible that with more data we would be able to build a 280 more informative predictive model. Second, we only include overweight and obese individuals in 281 our dataset due to the nature and design of the longitudinal study for which this data was 282 originally collected. It is thus possible that these CPMs for waist circumference and fasting 283 insulin do not generalize to lean individuals. However, since biomarkers are needed to evaluate 284 therapeutic interventions it can be argued that an overweight/obese sample is most appropriate. 285
Third, because the study design was not specifically optimized for use in this analysis, it remains 286 to be seen whether inclusion of tasteless blocks reduced our predictive power. Tasteless may be 287 more similar to a classic rest condition than milkshake. Across all studies implementing CPM, 288 resting state is least able to maximize detection of individual differences (19) . Fourth, we did not 289 use DEXA or whole-body MRI, which are considered the optimal measurement devices to 290 determine adiposity (48). Although, waist circumference and fasting insulin are more practical 291 measures, future work should validate our observations using the gold standard measures. 292
Finally, longitudinal studies are necessary to determine whether the obtained predictive networks 293 arise as a cause or consequence of increased fasting insulin and waist circumference. 294
Conclusions 295
Our analyses reveal that by characterizing whole brain connectivity during consumption of a 296 palatable energy-dense milkshake it is possible to predict an individual's waist circumference but 297 not BMI or percent body fat. This finding suggests that waist circumference is the phenotypic 298 marker of obesity that is most closely related to brain function during food consumption. 299
However, whether this brain biomarker is a cause or a consequence of waist size is unknown. We 300 were also able to predict fasting insulin but not glucose or HOMA-IR. Notably, although fasting 301 insulin reflects insulin resistance (49) and waist circumference has been shown to correlate with 302 insulin resistance, the CPMs predictive of waist circumference and fasting insulin were largely 303 distinct. 304 305
Materials and Methods 306
Participants 307
We recruited 100 overweight and obese individuals using media, flyer advertisements, and the 308 Yale Center for Clinical Investigation Help Us Discover database. Subjects were recruited to 309 participate in an ongoing clinical trial (NCT 01976156), but all related fMRI scans occurred at 310 baseline prior to any experimental manipulations. We screened participants via phone or online 311 to ensure they met the following criteria: right-handed, English-speaking, 18-45 years of age, 312 body mass index (BMI) of 25 or higher, nonsmokers, no psychiatric or neurological impairments 313 (including drug addiction, eating disorders), no obesity-related diseases such as type-2 diabetes, 314 no food allergies, no chemosensory impairments, and no MRI contraindications (pregnancy, 315 claustrophobia, metal implants, or prior head injury with loss of consciousness). In total, 67 316 participants (mean age = 30.7yrs, mean BMI = 33.3 ± 6.5) met these criteria and underwent 317 fMRI procedures. All participants provided written informed consent according to our protocol 318 that was approved by the Yale University School of Medicine Human Investigation Committee. 319
Measures 320
This study was part of a larger clinical trial (NCT 01976156). Below we outline the procedures 321 related to the baseline fMRI assessment, on which the analyses in this study are based. 322
Physical Characteristics and Diet 323
Participants arrived at the lab on the week of fMRI scanning for anthropometric measurements, 324 which included body weight, height, waist size, hip size, and adiposity. Adiposity, as described 325 by body fat percentage (BF%), was measured using air displacement plethysmography 326 (BodPod). Waist/Hip ratio and BMI (kg/cm 2 ) were subsequently calculated. Additional 327 participant characteristics are shown in Supplementary Table 1 . 328
Bloods 329
Following an overnight fast of 10-12 hours, blood samples were collected from 59 out of 67 330 subjects. We were unable to collect bloods on eight subjects due to venipuncture difficulty. 331
Samples were collected, centrifuged immediately, and then frozen at either 80 °C (insulin) or 20 332 °C (glucose). Insulin protein concentrations were subsequently measured using a 333 radioimmunoassay kit (APLCO insulin ELISA Catalog #80-INSHU-E01.1, Salem, NH) and 334 plasma glucose concentrations were determined using a glucose oxidase analyzer (YSI 335 Incorporated, Yellow Springs, OH). Insulin sensitivity was calculated using the homeostasis 336 model of insulin resistance, or HOMA-IR, which is based on the following formula: [insulin 337 (mU/L) x glucose (mmol/L)]/22.5 (50). 338
Image protocols 339
All fMRI scans were scheduled during the week of blood draws, sometime between 8:00 AM 340 and 12:00 PM. Participants were instructed to arrive neither full nor hungry, and adherence to 341 these instructions were confirmed using internal state ratings. Structural and functional imaging 342 The manifold consists of multiple channels that converge at a central point to allow delivery of a 373 liquid stimulus to the tongue tip. 374
Preprocessing 375
Neuroimaging data were preprocessed using SPM12 (Statistical Parametric Mapping, Wellcome 376 Department of Imaging Neuroscience, London, UK) and BioImage Suite (52). Participants' 377 functional images were corrected for geometric distortions resulting from susceptibility-induced 378 field inhomogeneities. The FieldMap toolbox in SPM12 was used to calculate static distortions 379 (53). Corrections were then made for both static distortions and changes in these distortions 380 resulting from head motion (54, 55). Images were realigned, unwarped, and coregistered to each 381 participant's anatomical T1 image and then processed using a method combining segmentation, 382 bias correction, and spatial normalization (56). Functional images were slice-time corrected, 383 normalized to a standard MNI template, and smoothed using a 6 mm FWHM isotropic Gaussian 384 kernel. Normalized, motion-corrected images were further preprocessed using BioImage Suite. 385
These additional steps included regression of the mean time courses of global signal, CSF, and 386 white matter, in addition to removal of the linear trend and low-pass filtering. 387
Construction of predictive networks 388
We performed Connectome-based Predictive Modeling (CPM; 14, 15, 18) to determine whether 389 task-based functional connectivity during milkshake receipt can predict individual differences in 390 anthropometric measurements. To accomplish this, we first used a whole-brain functional atlas 391 (57) to parcellate the brains of each subject into 268 nodes (i.e spatial ROIs) that maximize the 392 similarity of voxel-wise time courses within each node. 268x268 connectivity matrices for each 393 run were subsequently created in BioImage Suite by averaging the BOLD signal of each voxel 394 within nodes (52). Connectivity matrices were Fisher Transformed to convert the skewed 395 distribution of Pearson r (or Spearman rho) values to an approximately normal distribution. 396
Matrices were then averaged across runs to create a mean matrix for each subject, which were 397 then collapsed across subjects to create 268x268xN-subject matrices. 398
In the N-1 training set, CPM uses a linear regression (i.e. Pearson's r or Spearman's Rho) to 399 correlate each edge (i.e. connection) in each connectivity matrix to a behavioral measure of 400 interest. Each edge, as a result, is then associated with a particular p-value and the most relevant 401 edges are selected for further use via thresholding (P = 0.01). Edges that are positively correlated 402 with behavior constitute a "positive prediction network," while edges whose strengths are 403 negatively correlated with behavior constitute a "negative prediction network." Single-subject 404 summary values are then calculated by separately summing the edge-strengths of positive and 405 negative prediction networks (15). These positive and negative "network strengths" are used in a 406 linear model with behavior and applied prospectively to the left-out subject's network strengths 407 to generate predicted behavioral scores. 408
Permutation Testing 409
To determine the significance of the obtained correlations between observed and predicted 410 behavioral scores, we conducted 1000 repetitions of CPM using randomly shuffled observed 411 scores to generate predicted scores and networks. The 1000 correlation coefficients obtained 412 from permutation testing were used to comprise a null distribution against which the correlation 413 coefficients in the Results section were tested for significance. Final p-values were calculated by 414 determining the number of permutations, out of 1000, that generated correlation coefficients 415 larger than those reported in Results. 
Fig. 3. Exploratory Analysis of Fasting Insulin
CPM predicts fasting insulin levels (A). Positive and negative predictive networks are shown as hemisphere plots in (B). Notably, the number of positive and negative edges are highest among cerebellar and frontoparietal regions and the rest of the brain (C).
Fig. 4. Difference Matrices of Waist Circumference and Insulin
Matrices express the polarity in the number of positive versus negative edges between canonical networks adjusted for network size. For example, (A) shows more edges in the positive network exist between cerebellar and medial frontal nodes, while more edges in the negative network exist for cerebellar-cerebellar connections. Taken together, (A) and (B) demonstrate the greatest degree of similarity in connectivity patterns of cerebellar and subcortical networks in waist circumference and fasting insulin CPMs.
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Fig. 5. Top 10% High-Degree Nodes for Waist Circumference and Fasting Insulin CPMs
Top 10% high-degree nodes (27 nodes total) for waist circumference (A) encompass networks spanning the whole brain and include nodes varying in degree from 21 to 7. (B) The CPM for fasting insulin is similarly encompassing, with nodes varying in degree from 11 to 3.
Fig. 6. Difference of Top 10% Nodes between Waist Circumference and Fasting Insulin
CPMs (A) High-degree nodes (top 10%) participating in the waist circumference CPM but not the fasting insulin CPM (B) Nodes in the top 10% participating in the fasting insulin CPM but not the waist circumference CPM. 
